Clinical Trial Update: Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating sorafenib tosylate with gene expression analysis in patients undergoing surgery for high-risk localized prostate cancer has completed,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Sorafenib tosylate (sorafenib tosylate)

Snippet

Sponsor: University of Washington | Conditions: Adenocarcinoma of the Prostate, Stage II Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-11-22